Vaxfab Enterprises Ltd Intrinsic Value
VEL · Services · Current price ₹60
Is Vaxfab Enterprises Ltd undervalued?
DocStoX estimates the fair value of Vaxfab Enterprises Ltd at ₹16 per share, versus the current market price of ₹60. That puts the stock about -73.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹16). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹14 (bear) to ₹16 (base) to ₹18 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹60 versus an intrinsic value of ₹16, Vaxfab Enterprises Ltd currently offers -73.3% of negative margin (i.e. a premium).
More on Vaxfab Enterprises Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.